POINT BIOPHARMA GLOBAL INC (PNT)
US7305411099 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 96.60M | 98.30M | -45.90M | -13.40M | 0.00 | |||
| Depreciation Amortization | 2.60M | 1.40M | N/A | N/A | N/A | |||
| Income Taxes - Deferred | N/A | 1.40M | 100.00K | N/A | N/A | |||
| Change In Working Capital | 15.80M | 80.90M | -1.20M | 3.20M | 0.00 | |||
| Interest Paid | N/A | 0.00 | 100.00K | N/A | N/A | |||
| Taxes Paid | 32.00M | 500.00K | 100.00K | N/A | N/A | |||
| Other non cash items | -5.20M | 1.60M | 2.30M | 1.80M | N/A | |||
| OPERATING CASH FLOW | 112.00M | 183.50M | -44.70M | -8.30M | 0.00 | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -19.30M | -12.80M | -8.80M | -9.80M | N/A | |||
| Other Investing Activity | -210.50M | -253.50M | N/A | -135.70M | 0.00 | |||
| INVESTING CASH FLOW | -229.80M | -266.30M | -8.80M | -9.80M | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -3.60M | 3.60M | N/A | |||
| Stock Issued/Repurchased | 13.80M | 130.40M | 285.30M | 25.40M | N/A | |||
| Other Financing Activity | N/A | N/A | 0.00 | -300.00K | 0.00 | |||
| FINANCING CASH FLOW | 13.50M | 130.40M | 281.80M | 28.70M | 0.00 | |||
| CHANGE IN CASH | -104.30M | 47.60M | 228.30M | 10.60M | 0.00 | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 112.00M | 183.50M | -44.70M | -8.30M | 0.00 | |||
| Capital Expenditure | -19.30M | -12.80M | -8.80M | -9.80M | N/A | |||
| FREE CASH FLOW | 92.70M | 170.70M | -53.50M | -18.10M | 0.00 | |||
All data in USD